EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) shares saw an uptick in trading volume on Monday . 283,301 shares traded hands during trading, an increase of 129% from the previous session’s volume of 123,744 shares.The stock last traded at $95.86 and had previously closed at $95.00.

Wall Street Analyst Weigh In

ESLOY has been the subject of several research analyst reports. The Goldman Sachs Group downgraded shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating for the company. Finally, Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy”.

Read Our Latest Report on EssilorLuxottica

EssilorLuxottica Stock Up 0.7%

The firm’s 50-day moving average is $99.57 and its 200 day moving average is $121.41. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Articles

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.